Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Kottner

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
The Cochrane Database of Systematic Reviews|November 15, 2016
Interventions for preventing and treating incontinence-associated dermatitis in adultsDimitri Beeckman, Nele Van Damme, Lisette Schoonhoven, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
Journal of Advanced Nursing|March 10, 2018
Core outcome domains in incontinence-associated dermatitis researchKaren Van den Bussche, Jan Kottner, Hilde Beele, et al.
BMJ Open|February 6, 2024
Protocol of a scoping review of outcome domains in dermatologyUmer Nadir, Areeba Ahmed, Michael D Yi, et al.
The Journal of Investigative Dermatology|December 12, 2018
Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More UsableJochen Schmitt, Toni Lange, Jan Kottner, et al.
Skin Pharmacology and Physiology|May 31, 2021
A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin PathwayVarvara Kanti, Lia Puder, Irina Jahnke, et al.
The British Journal of Dermatology|June 12, 2024
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosaEva W H Korte, Anna M G Pasmooij, Maria C Bolling, et al.
Journal of Clinical Epidemiology|October 29, 2021
Use of core outcome sets was low in clinical trials published in major medical journalsKaren Matvienko-Sikar, Kerry Avery, Jane M Blazeby, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical TrialsSilvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
The Cochrane Database of Systematic Reviews|November 15, 2016
Interventions for preventing and treating incontinence-associated dermatitis in adultsDimitri Beeckman, Nele Van Damme, Lisette Schoonhoven, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
Journal of Advanced Nursing|March 10, 2018
Core outcome domains in incontinence-associated dermatitis researchKaren Van den Bussche, Jan Kottner, Hilde Beele, et al.
BMJ Open|February 6, 2024
Protocol of a scoping review of outcome domains in dermatologyUmer Nadir, Areeba Ahmed, Michael D Yi, et al.
The Journal of Investigative Dermatology|December 12, 2018
Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More UsableJochen Schmitt, Toni Lange, Jan Kottner, et al.
Skin Pharmacology and Physiology|May 31, 2021
A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin PathwayVarvara Kanti, Lia Puder, Irina Jahnke, et al.
The British Journal of Dermatology|June 12, 2024
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosaEva W H Korte, Anna M G Pasmooij, Maria C Bolling, et al.
Journal of Clinical Epidemiology|October 29, 2021
Use of core outcome sets was low in clinical trials published in major medical journalsKaren Matvienko-Sikar, Kerry Avery, Jane M Blazeby, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical TrialsSilvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Pageof 25